Company overview
CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops Auxora for the treatment of acute ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory indications. The company is based in La Jolla, California.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing CALC with another company.
| Daily close (USD) | $1.3 |
| Market capitalization (USD) | $8,876,779.6 |
| Price / earnings (TTM) | Not reported |
| Price / book | 1.61 |
No matching rows. Clear the filter to see all records.
Read CALC's valuation metrics
Company size
CalciMedica, Inc. Common Stock's recorded market capitalization is $8,876,779.6. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
CALC's recorded price-to-book ratio is 1.61. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research CalciMedica, Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about CALC. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow CALC's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.